Short Interest in BIO-key International, Inc. (NASDAQ:BKYI) Rises By 6,659.4%

BIO-key International, Inc. (NASDAQ:BKYIGet Free Report) was the target of a large increase in short interest in the month of October. As of October 31st, there was short interest totalling 865,200 shares, an increase of 6,659.4% from the October 15th total of 12,800 shares. Based on an average daily trading volume, of 4,850,000 shares, the short-interest ratio is presently 0.2 days. Currently, 30.9% of the company’s shares are sold short.

BIO-key International Stock Down 1.9 %

NASDAQ:BKYI opened at $1.03 on Thursday. The firm’s 50 day simple moving average is $1.04 and its 200 day simple moving average is $1.40. The company has a current ratio of 0.54, a quick ratio of 0.46 and a debt-to-equity ratio of 0.28. BIO-key International has a one year low of $0.52 and a one year high of $4.43.

BIO-key International (NASDAQ:BKYIGet Free Report) last posted its earnings results on Wednesday, August 14th. The technology company reported ($1.00) EPS for the quarter, missing the consensus estimate of ($0.54) by ($0.46). BIO-key International had a negative return on equity of 673.82% and a negative net margin of 93.18%. The business had revenue of $1.14 million for the quarter.

BIO-key International Company Profile

(Get Free Report)

BIO-key International, Inc develops and markets fingerprint identification biometric technology and software solutions, and enterprise-ready identity access management solutions for commercial, government, and education customers in the United States and internationally. The company offers BIO-key PortalGuard and PortalGuard IDaaS solutions, a customer-controlled and neutral-by-design cloud-based identity platform that allows customers to integrate with any cloud or on-premises SaaS application, as well as windows device authentication through IAM platform.

See Also

Receive News & Ratings for BIO-key International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BIO-key International and related companies with MarketBeat.com's FREE daily email newsletter.